EDAP TMS SA (NASDAQ:EDAP) — Market Cap & Net Worth
Market Cap & Net Worth: EDAP TMS SA (EDAP)
EDAP TMS SA (NASDAQ:EDAP) has a market capitalization of $126.31 Million ($126.31 Million) as of May 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #18284 globally and #4054 in its home market, demonstrating a 5.47% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying EDAP TMS SA's stock price $3.47 by its total outstanding shares 37481986 (37.48 Million). Analyse EDAP operating cash flow to see how efficiently the company converts income to cash.
EDAP TMS SA Market Cap History: 2015 to 2026
EDAP TMS SA's market capitalization history from 2015 to 2026. Data shows change from $154.80 Million to $130.06 Million (-2.64% CAGR).
Index Memberships
EDAP TMS SA is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.41 Trillion | 0.01% | #512 of 976 |
|
NASDAQ Composite
IXIC
|
$38.77 Trillion | 0.00% | #1783 of 3165 |
Weight: EDAP TMS SA's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
EDAP TMS SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how EDAP TMS SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.74x
EDAP TMS SA's market cap is 1.74 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $122.94 Million | $35.61 Million | $3.84 Million | 3.45x | 32.00x |
| 2017 | $107.57 Million | $35.75 Million | -$681.00K | 3.01x | N/A |
| 2018 | $69.34 Million | $39.18 Million | -$338.00K | 1.77x | N/A |
| 2019 | $166.05 Million | $44.91 Million | $1.51 Million | 3.70x | 109.82x |
| 2020 | $193.78 Million | $41.66 Million | -$1.70 Million | 4.65x | N/A |
| 2021 | $224.52 Million | $44.07 Million | $700.00K | 5.10x | 320.74x |
| 2022 | $399.56 Million | $55.11 Million | -$2.93 Million | 7.25x | N/A |
| 2023 | $197.90 Million | $60.42 Million | -$21.18 Million | 3.28x | N/A |
| 2024 | $82.84 Million | $64.11 Million | -$19.02 Million | 1.29x | N/A |
| 2025 | $123.32 Million | $70.75 Million | -$29.34 Million | 1.74x | N/A |
Competitor Companies of EDAP by Market Capitalization
Companies near EDAP TMS SA in the global market cap rankings as of May 4, 2026.
Key companies related to EDAP TMS SA by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #246 globally with a market cap of $99.71 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #441 globally with a market cap of $59.14 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #570 globally with a market cap of $45.94 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1111 globally with a market cap of $22.95 Billion USD ( AU$32.44 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #246 | McKesson Corporation | NYSE:MCK | $99.71 Billion | $814.02 |
| #441 | Cencora Inc. | NYSE:COR | $59.14 Billion | $304.00 |
| #570 | Cardinal Health Inc | NYSE:CAH | $45.94 Billion | $195.24 |
| #1111 | Sigma Healthcare Ltd | AU:SIG | $22.95 Billion | AU$2.81 |
EDAP TMS SA Historical Marketcap From 2015 to 2026
Between 2015 and today, EDAP TMS SA's market cap moved from $154.80 Million to $ 130.06 Million, with a yearly change of -2.64%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $130.06 Million | +5.47% |
| 2025 | $123.32 Million | +48.87% |
| 2024 | $82.84 Million | -58.14% |
| 2023 | $197.90 Million | -50.47% |
| 2022 | $399.56 Million | +77.96% |
| 2021 | $224.52 Million | +15.86% |
| 2020 | $193.78 Million | +16.70% |
| 2019 | $166.05 Million | +139.46% |
| 2018 | $69.34 Million | -35.54% |
| 2017 | $107.57 Million | -12.50% |
| 2016 | $122.94 Million | -20.58% |
| 2015 | $154.80 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of EDAP TMS SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $126.31 Million USD |
| MoneyControl | $126.31 Million USD |
| MarketWatch | $126.31 Million USD |
| marketcap.company | $126.31 Million USD |
| Reuters | $126.31 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About EDAP TMS SA
EDAP TMS S.A., together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU s… Read more